过去一年中添加的文章，按日期排序
[HTML][HTML] Subsequent Vaccination against SARS-CoV-2 after Vaccine-Induced Immune Thrombotic Thrombocytopenia
G Uzun, T Ringelmann, S Hammer, J Zlamal… - Journal of Clinical …, 2024 - mdpi.com
2 天前 - … This report details the clinical and serological follow-up of four patients who
developed VITT after ChAdOx1 nCoV-19 vaccination and subsequently received BNT162b2 as a …
developed VITT after ChAdOx1 nCoV-19 vaccination and subsequently received BNT162b2 as a …
Comprehensive Humoral and Cellular Immune Responses to Covid-19 Vaccination In Adults with Cancer
3 天前 - … malignancies receiving up to five COVID-19 vaccine doses. Antibody response
was … mRNA vaccine (BNT162b2=347; mRNA-1273=1) or viral vector vaccine (ChadOx1-S=43) …
was … mRNA vaccine (BNT162b2=347; mRNA-1273=1) or viral vector vaccine (ChadOx1-S=43) …
Human papilloma virus vaccine induced thrombocytopenia accompanied by a wide spectrum of reversible inflammatory responses–a case report
S Holm, AE Michelsen, NH Schultz… - … Journal of Clinical …, 2024 - Taylor & Francis
4 天前 - … PTX3 during the acute phase in HPV vaccinated patients as compared to the
controls (un-complicated ChAdOx1 nCoV-19 vaccinated (n = 5–8) and not vaccinated (n = 8–11)), …
controls (un-complicated ChAdOx1 nCoV-19 vaccinated (n = 5–8) and not vaccinated (n = 8–11)), …
Willingness to receive a COVID-19 vaccine among pregnant Thai women during the COVID-19 pandemic
P Chaiyakiat, F Chiewbangyang… - Thai Journal of …, 2024 - he02.tci-thaijo.org
6 天前 - … COVID-19 vaccines and were asked about their vaccine … to determine factors
associated with vaccine acceptance. … vaccine (29.7%) and ChAdOx1-S adenoviral-vectored …
associated with vaccine acceptance. … vaccine (29.7%) and ChAdOx1-S adenoviral-vectored …
Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses
DL Padilla-Bórquez, MG Matuz-Flores… - Human Vaccines & …, 2024 - Taylor & Francis
7 天前 - … ChAdOx1 nCoV-19 vaccine, which uses a modified chimpanzee adenovirus (ChAdOx1…
Individuals who received the ChAdOx1 nCoV-19 vaccine displayed more side effects …
Individuals who received the ChAdOx1 nCoV-19 vaccine displayed more side effects …
[HTML][HTML] The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination
10 天前 - … in the BNT162b2 and ChAdOx1 vaccine cohorts, we conducted … and to enroll
participants who received the COVID-19 vaccine … In conclusion, the longevity of COVID-19 vaccine …
participants who received the COVID-19 vaccine … In conclusion, the longevity of COVID-19 vaccine …
[PDF][PDF] Navigating the Pandemic: A Review of the Impact of COVID-19 Outbreaks in Correctional Homes of West Bengal
P Pal - multiarticlesjournal.com
12 天前 - … or ChAdOx1, developed by Oxford University scientists. India is also developing
its vaccine, … COVID-19: Efforts to increase vaccine availability and perspectives on initial …
its vaccine, … COVID-19: Efforts to increase vaccine availability and perspectives on initial …
Post COVID-19 vaccination binding and neutralizing antibody with or without previous infection: An 18-month longitudinal study in Indonesia
TD Ardyanto, K Khariri, TP Agus, A Subandrio - Narra J, 2024 - narraj.org
17 天前 - … antibody responses in people after receiving CoronaVac or ChAdOx1 vaccines
with or without a history of SARS-CoV-2 infection. Conducted in Indonesia between August …
with or without a history of SARS-CoV-2 infection. Conducted in Indonesia between August …
Injuries and deaths following Covid-19 vaccination: The ethical and legal case for compensation
V Johari, S Srinivasan - Indian journal of medical ethics, 2024 - pubmed.ncbi.nlm.nih.gov
21 天前 - … vaccination with AstraZeneca's (AZ) Covid-19 vaccine [1], the manufacturer
admitted in a UK court that the Oxford-AZ Covid-19 vaccine … SARS-CoV2 spike protein (ChAdOx1-S) …
admitted in a UK court that the Oxford-AZ Covid-19 vaccine … SARS-CoV2 spike protein (ChAdOx1-S) …
Alterations of plasma metabolomes and their correlations with immunogenicity in maintenance hemodialysis patients receiving different COVID‐19 vaccine regimens
P Narongkiatikhun, C Thonusin… - Physiological …, 2024 - Wiley Online Library
27 天前 - … (Sinovac, Beijing, China) against SARS-CoV-2 (SV-SV), homologous replication-defective
viral vectors ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 (AZ-AZ), …
viral vectors ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 (AZ-AZ), …